Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
21 Nov 2026, 2:00 pm
Eligibility, documents, scope, Go/No-Go checksEligibility, required documents, scope of work and Go/No-Go checks for this tender, in one click.
Published by the portal on this tender, for queries and grievance redressal.
ECHS CFA RE 160
10153478
GEM/2026/B/8263304
Two Packet Bid
AKT 4 KIT ISONIAZID 300MG RIFAMPICIN 450MG
Central Delhi, Delhi
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
10%
Exempted
Yes
11 Nov 2026
11 Nov 2026
22 Nov 2026
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|
| 1 | AKT 4 KIT ISONIAZID 300MG RIFAMPICIN 450MG ETHAMBUTOL 800MG PYRAZINAMIDE 750MG | 920 | Kit | Central Delhi | 15 |
| 2 | ALENDRONATE SODIUM 70 MG TAB | 1,120 | No | Central Delhi | 15 |
| 3 | AMIODARONE 100 MG TAB | 21,400 | No | Central Delhi | 15 |
| 4 | ANASTRAZOLE 1 MG TAB | 7,600 | No | Central Delhi | 15 |
| 5 | NITROGLYCERIN TR 2 POINT 5 MG TAB | 25,000 | No | Central Delhi | 15 |
| 6 | POVIDONE IODINE BETADINE 1 PERCENT | 1,490 | Bott | Central Delhi | 15 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_10153478.pdf
GEM_BID • 0.12 MB
img_0003_2026-11-11-13-39-50_cf1fd36fbe67711a4386247342986826.pdf
BOQ • 0.48 MB
boq_item_sample_file_2026-11-11-13-39-50_e608ef09fe485d391072634b9b44fac2.csv
BOQ • 0.00 MB
GEM_OTHER • 1.82 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .